LINC01270
gene geneOn this page
Summary
LINC01270 (long intergenic non-protein coding RNA 1270, HGNC:27658) is a long non-coding RNA gene on chromosome 20q13.13.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27658 |
| Approved symbol | LINC01270 |
| Name | long intergenic non-protein coding RNA 1270 |
| Location | 20q13.13 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000203999 |
| Ensembl biotype | lncRNA |
| Entrez | 284751 |
| RNAcentral | URS000075EEAB — lncRNA, 2278 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 17 — 17 lncRNA
ENST00000371639, ENST00000457853, ENST00000653657, ENST00000653865, ENST00000653970, ENST00000655316, ENST00000655675, ENST00000655925, ENST00000661795, ENST00000662382, ENST00000663616, ENST00000664104, ENST00000669676, ENST00000671482, ENST00000701020, ENST00000718356, ENST00000718357
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000371639 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001455726 | 50298156 | 50298413 |
| ENSE00001455727 | 50292720 | 50292830 |
| ENSE00001542574 | 50312352 | 50312430 |
| ENSE00001542575 | 50311805 | 50312014 |
| ENSE00003884961 | 50313300 | 50314923 |
Expression profiles
Bgee: expression breadth ubiquitous, 151 present calls, max score 79.10.
FANTOM5 (CAGE): breadth broad, TPM avg 1.3574 / max 94.0697, expressed in 586 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185237 | 0.5776 | 321 |
| 185243 | 0.2945 | 47 |
| 185238 | 0.2135 | 81 |
| 185240 | 0.1779 | 39 |
| 185242 | 0.0939 | 31 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 79.10 | gold quality |
| blood | UBERON:0000178 | 76.74 | gold quality |
| right adrenal gland | UBERON:0001233 | 76.17 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.84 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.10 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.82 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 73.39 | gold quality |
| spleen | UBERON:0002106 | 72.06 | gold quality |
| adrenal cortex | UBERON:0001235 | 71.57 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.95 | gold quality |
| adrenal gland | UBERON:0002369 | 70.72 | gold quality |
| granulocyte | CL:0000094 | 69.23 | gold quality |
| vermiform appendix | UBERON:0001154 | 68.98 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 68.27 | gold quality |
| muscle of leg | UBERON:0001383 | 67.87 | gold quality |
| gastrocnemius | UBERON:0001388 | 67.24 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 67.17 | gold quality |
| liver | UBERON:0002107 | 67.15 | gold quality |
| right lung | UBERON:0002167 | 66.58 | gold quality |
| leukocyte | CL:0000738 | 66.19 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 66.03 | gold quality |
| monocyte | CL:0000576 | 65.92 | gold quality |
| thyroid gland | UBERON:0002046 | 64.45 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 63.96 | gold quality |
| apex of heart | UBERON:0002098 | 63.93 | gold quality |
| left uterine tube | UBERON:0001303 | 63.29 | gold quality |
| upper lobe of lung | UBERON:0008948 | 63.11 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 62.77 | gold quality |
| caecum | UBERON:0001153 | 62.77 | gold quality |
| right atrium auricular region | UBERON:0006631 | 62.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.60 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation. (PMID:33199829)
- LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis. (PMID:35345980)
- Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway. (PMID:36241925)
- Abnormal expression of long non-coding RNA LINC01270 in glioma and its correlation with X-ray computed tomography signs. (PMID:38587325)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.